Poongjeon Pharmacy CO.,LTD. (KOSDAQ:298060)

KOSDAQ:298060 Revenue

Poongjeon Pharmacy CO.,LTD. had revenue of 11.99B KRW in the quarter ending June 30, 2026, with 7,386.37% growth. This brings the company's total for the last twelve months to 1.54B, up 53.75% year-over-year. In the year 2024, Poongjeon Pharmacy CO.,LTD. had annual revenue of 824.80M with 18.56% growth. That makes Poongjeon Pharmacy CO.,LTD. the 43,347th largest company in the world by revenue and 2,580th in South Korea.

• Revenue (ttm): 1.54B
• Revenue Growth: +53.75%
• P/S Ratio: 13.03
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 20.11B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Stem Cell 764.58M 92.7%
• License 60.23M 7.3%

By Geography

• South Korea 775.82M 94.1%
• Overseas 48.98M 5.9%

Fiscal year ended Dec 31, 2024 See the full KOSDAQ:298060 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	824.80M	129.10M	18.56%
Dec 31, 2023	695.70M	299.72M	75.69%
Dec 31, 2022	395.98M	-43.28M	-9.85%
Dec 31, 2021	439.26M	119.26M	37.27%
Dec 31, 2020	320.01M	151.51M	89.92%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error